Tsukamoto T | Department Of Public Health Osaka City University Graduate School Of Medicine
スポンサーリンク
概要
関連著者
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Tatematsu M
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
SHIRAI Norimitsu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Inada Ken-ichi
Department Of Pathology Fujita Health University School Of Medicine
-
Imaida Katsumi
大雄会医科学研究所
-
MIZOSHITA Tsutomu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
Takahashi M
National Inst. Health Sci. Tokyo
-
今井 敏夫
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
YANAI Tokuma
Department of Veterinary Pathology, Gifu University
-
MASEGI Toshiaki
Department of Veterinary Pathology, Gifu University
-
CAO Xueyuan
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
IIDAKA Takeshi
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Iidaka Takeshi
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
KAMINISHI Michio
Department of Gastrointestinal Surgery, The University of Tokyo, Graduate School of Medicine
-
TSUKAMOTO Tetsuya
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
YAMAMOTO Masami
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
HIRATA Akihiro
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TAKENAKA Yoshiharu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
NOZAKI Koji
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Takami Toshihiro
Department Of Neurosurgery Suisyoukai Murata Hospital
-
BAN Hisayo
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TANAKA Harunari
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
KUMAGAI Toshiko
Central Clinical Laboratories, Shinshu University Hospital
-
INADA Ken-ichi
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TANAKA Takashi
Department of Physics, Faculty of Science, Okayama University
-
SAKAI Hiroki
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
OGASAWARA Naotaka
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
KATO Sosuke
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
SHIMIZU Nobuyuki
Department of Gastrointestinal Surgery, Postgraduate School of Medicine, The University of Tokyo
-
WAKABAYASHI Keiji
Cancer Prevention Division, National Cancer Center Research Institute
-
FURIHATA Chie
College of Science and Engineering, Aoyama Gakuin University
-
高橋 正好
(独)産業技術総合研究所 環境管理技術研究部門
-
Takami Shigeaki
Division of Pathology, National Institute of Health Sciences
-
TAKASU Shinji
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TOYODA Takeshi
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
SAKAI Hiroki
Department of Veterinary Pathology, Gifu University
-
YAMAMOTO Masami
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
INADA Ken-ichi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
Miki Tokutaro
名古屋市立大学 医学研究科 実験病態病理
-
WAKASA Kenichi
Department of Pathology, Osaka City University Hospital
-
Ushijima Toshikazu
Carcinogenesis Division, National Cancer Center Research Institute
-
DONEHOWER Lawrence
Department of Molecular Virology and Microbiology, Baylor College of Medicine
-
JOH Takashi
Department of Internal Medicine and Bioregulation, Nagoya City University Medical School
-
YAMAMURA Yoshitaka
Department of Gastroenterological Surgery, Aichi Cancer Center Hospital
-
TOTSUKA Yukari
Cancer Prevention Division, National Cancer Center Research Institute
-
IKEHARA Yuzuru
Divisions of Oncological Pathology, Aichi Cancer Center Research Institute
-
HIRATA Akihiro
Department of Veterinary Pathology, Gifu University
-
INOUE Manami
Epidemiology & Prevention, Aichi Cancer Center Research Institute
-
SUGIYAMA Atsushi
First Department of Surgery, Shinshu University
-
SHIRAI Norimitsu
Laboratory of Oncological Pathology, Aichi Cancer Center Research Institute
-
INAGAMI Atsushi
Department of Veterinary Pathology, Gifu University
-
FUKAMI Hiroko
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
SHIMIZU Nobuyuki
Laboratory of Pathology, Aichi Cancer Research Institute
-
NAKANISHI Hayao
Laboratory of Pathology, Aichi Cancer Research Institute
-
YOSHIKAWA Akemi
Laboratory of Pathology, Aichi Cancer Research Institute
-
KOBAYASHI Kiyoshi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
ANDO Yasumi
Department of Cancer Research, Hiroshima University
-
WATANABE Hiromitsu
Department of Cancer Research, Hiroshima University
-
FUJIMOTO Nariaki
Department of Cancer Research, Hiroshima University
-
TOGE Tetsuya
Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima Un
-
ITO Akihiro
Department of Cancer Research, Hiroshima University
-
Miki Tokutaro
Research And Development Division Nippon Hypox Laboratories Inc.
-
Hayashi Yoshitake
Department Of Public Health Osaka City University Graduate School Of Medicine
-
NAKANISHI Hayao
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Hirohashi Kazuhiro
大阪市立大学 医学研究科肝胆膵外科学
-
金井 直樹
北見赤十字病院耳鼻咽喉科・頭頸部外科
-
TAKAHASHI Kenji
Department of Radiological Life Sciences, Hirosaki University Graduate School of Health Sciences
-
UTSUNOMIYA Hirotoshi
Department of Strategic Surveillance for Functional Food and Comprehensive Traditional Medicine, Wak
-
小西 陽一
奈良県立医科大学腫瘍病理
-
Cho Young-Man
Division of Pathology, National Institute of Health Sciences
-
Hirose Masao
Division of Pathology, National Institute of Health Sciences
-
早川 和宏
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
木下 博明
大阪市立大学大学院
-
木下 博明
大阪市立大学第2外科
-
木下 博明
大阪市立大学医学部附属病院 第2外科
-
YAMAMOTO Takatsugu
Department of Internal Medicine, Teikyo University School of Medicine
-
小西 陽一
奈良医大
-
YAMAMOTO Satoshi
Department of Physiology, Kurume University School of Medicine
-
Yamazaki Osamu
Department of Hepato-Biliary-Pancreatic Surgery, OsakaCity University, Graduate School of Medicine
-
NAKAE Dai
Department of Environmental Health and Toxicology, Tokyo Metropolitan Institute of Public Health
-
Mori H
Division Of Pathology National Institute Of Health Sciences
-
Yamazaki Osamu
Department Of Gastrointestinal Surgery Osaka City General Hospital
-
Yamazaki Osamu
大阪市立総合医療センター 肝臓内科
-
Sakaki Y
Riken Genomic Sciences Center
-
FURUKAWA Fumio
Division of Pathology, National Institute of Health Sciences
-
Nakae D
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health:toky
-
Nakae D
Department Of Pathology Sasaki Institute Sasaki Foundation
-
Nakae Dai
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
CAO Xue-Yuan
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
OSHIMA Masanobu
Division of Genetics, Cancer Research Institute, Kanazawa University
-
ENOMOTO Shotaro
Carcinogenesis Division, National Cancer Center Research Institute
-
MAEKITA Takao
Carcinogenesis Division, National Cancer Center Research Institute
-
NAKAJIMA Takeshi
Carcinogenesis Division, National Cancer Center Research Institute
-
NAKAZAWA Kazuyuki
Second Department of Internal Medicine, Wakayama Medical University
-
ICHINOSE Masao
Second Department of Internal Medicine, Wakayama Medical University
-
NISHIBE Sansei
Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido
-
DEYAMA Takeshi
Central Research Laboratories, Yomeishu Seizo Co., Ltd
-
HIRANO Naoki
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
YOKOI Takio
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital
-
MARUTA Shinya
Department of Internal Medicine, Tokai Hospital
-
KITAMURA Masakazu
Department of Internal Medicine, Tokai Hospital
-
YAMAMOTO Tsuyoshi
Department of Internal Medicine, Tokai Hospital
-
OTSUKA Takafumi
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
MIKI Kazumasa
Division of Gastroenterology and Hepatology, Department of Medicine, Toho University School of Medic
-
NOZAKI Koji
Department of Gastrointestinal Surgery, Postgraduate School of Medicine, The University of Tokyo
-
IIDAKA Takeshi
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
SHIRAI Norimitsu
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
ITOH Makoto
Department of Internal Medicine and Bioregulation, Nagoya City University Medical School
-
YAMAMURA Yoshitaka
Division of Gastroenterological Surgery, Aichi Cancer Center Hospital
-
NOMOTO Tomoko
Carcinogenesis Division, National Cancer Center Research Institute
-
FUJITA Hirofumi
Japan Bioassay Research Center
-
MATSUSHIMA Taijiro
Japan Bioassay Research Center
-
SHIRAI NORIMITSU
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
IIDAKA TAKESHI
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
INOUE Manami
Divisions of Epidemiology & Prevention, Aichi Cancer Center Research Institute
-
HIRANO Kazuyuki
Laboratory of Pharmaceutics, Gifu Pharmaceutical University
-
TATEMATSU Masase
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
SIMIZU Nobuyuki
Department of Gastrointestinal Surgery, Postgraduate School of Medicine, The University of Tokyo
-
FUKUSHIMA Shoji
Department of Pathology, Osaka City University Medical School
-
WANIBUCHI Hideki
Department of Pathology, Osaka City University Medical School
-
MORIMURA Keiichirou
Department of Pathology, Osaka City University Medical School
-
WEI Min
Department of Pathology, Osaka City University Medical School
-
KONISHI Yoichi
Department of Oncological Pathology, Cancer Center, Nara Medical University
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
UEHARA Nobuaki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
IMAIDA katsumi
Department of Pathology, Nagoya City University Medical School
-
SHIRAI Tomoyuki
Department of Pathology, Nagoya City University Medical School
-
MAENG Hack-Young
Human Genome Center, Institute of Medical Science, University of Tokyo
-
CHOI Dong-Kug
Human Genome Center, Institute of Medical Science, University of Tokyo
-
TAKEUCHI Motoi
Human Genome Center, Institute of Medical Science, University of Tokyo
-
TOMINAGA Michiyo
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
ITO Takashi
Human Genome Center, Institute of Medical Science, University of Tokyo
-
SAKAKI Yoshiyuki
Human Genome Center, Institute of Medical Science, University of Tokyo
-
FURIHATA Chie
Human Genome Center, Institute of Medical Science, University of Tokyo
-
OKAMURA Miwa
Department of Veterinary Pathology, Gifu University
-
TAKAHASHI Naofumi
Department of Veterinary Pathology, Gifu University
-
INAGAMI Atsushi
Developmental Safety Assessment Research Drug & Disposition Research Laboratories Eisai Co., Ltd.
-
IIDAKA Takashi
Laboratory of Oncological Pathology, Aichi Cancer Center Research Institute
-
SAKAI Hiroki
Laboratory of Oncological Pathology, Aichi Cancer Center Research Institute
-
KOBAYASHI Kiyoshi
Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals. Inc.
-
DEGAWA Masakuni
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
IIDAKA Takeshi
Laboratory of Oncological Pathology, Aichi Cancer Center Research Institute
-
TANAKA Harunari
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
INOUE Manami
Laboratory of Epidemiology, Aichi Cancer Center Research Institute
-
TAKAHASHI Mami
Cancer Prevention Division, National Cancer Center Research Institute
-
TUKAMOTO Tetsuya
Laboratories of Pathology
-
KOZAKI Ken-ichi
Pathophysiology Unit, Aichi Cancer Center Research Institute
-
NISHIKAWA Youko
Pathophysiology Unit, Aichi Cancer Center Research Institute
-
田代 俊文
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
中野渡 純一
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
福田 種男
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
細川 暁
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
塚本 徹哉
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
稲田 健一
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
立松 正衞
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
YAMACHIKA Takasuke
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
FUKUSHIMA Shoji
First Department of Pathology, Osaka City University Medical School
-
NAKAMURA Wataru
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
HIRANO Kazuyuki
Gifu Pharmaceutical University
-
INOUE Hanae
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
KITO Kuniyoshi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
GOTO Kazuhiro
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
MUTAI Mamoru
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
IMAI Toshio
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
ICHINOSE Masutaro
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
NAKAMURA Toshikazu
Biomedical Research Center, Osaka University School of Medicine
-
KITOH Kuniyoshi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
HIRANO Kazuyuki
Department ofPharmaceutics, Glfu Pharmaceutical University
-
FURIHATA Chie
Department of Molecular Oncology, Institute of Medical Science, University of Tokyo
-
Iidaka Takeshi
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
HIROHASHI Kazuhiro
Department of Surgery, Osaka City University Medical School
-
KUBO Shoji
Department of Surgery, Osaka City University Medical School
-
IMAIDA Katsumi
Onco-Pathology, Faculty of Medicine, Department of Pathology and Host-Defense, Kagawa University
-
Fukushima S
Japan Bioassay Research Center Japan Industrial Safety And Health Association
-
Imaida K
Onco-pathology Faculty Of Medicine Department Of Pathology And Host-defense Kagawa University
-
Imaida Katsumi
国立がんセンター研究所 がん予防基礎研究プロジェクト
-
Imaida Katsumi
Department Of Onco-pathology Faculty Of Medicine Kagawa University
-
Konishi Y
Department Of Oncological Pathology Cancer Center Nara Medical University
-
Konishi Yoichi
奈良県立医科大学附属がんセンター 腫瘍病理学
-
Cho Young-man
Division Of Pathology National Institute Of Health Sciences
-
Cho Young-man
国立医薬品食品衛生研究所 病理部
-
TAKAOKA Kunio
Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine
-
Kinoshita Hiroaki
Department Of General Practice Osaka City University Hospital
-
Hirohashi K
The Second Department Of Surgery And Department Of Cardiovascular Surgery Osaka City University Medi
-
Nakajima Shigeo
箕面市立病院 小児科
-
Nakajima Shigeo
Department Of Pediatrics Osaka University Graduate School Of Medicine
-
ICHINOSE Masao
First Department of Internal Medicine, Faculty of Medicine, University of Tokyo
-
Wanibuchi Hideki
Department Of Pathology Osaka City University Medical School
-
Wanibuchi Hideki
大阪府立成人病センター 分子生物学
-
Wei Min
Department Of Pathology Osaka City University Medical School
-
Furukawa F
Division Of Pathology National Institute Of Health Sciences
-
Furukawa Fumio
国立衛生試験所
-
Furukawa Fumio
Division Of Pathology National Institute Of Health Sciences
著作論文
- Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and β-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice
- Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae
- Inhibitory effect of nordihydroguaiaretic acid, a plant lignan, on Helicobacter pylori-associated gastric carcinogenesis in Mongolian gerbils
- Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)
- Gastric adenocarcinoma with chief cell differentiation
- Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models
- Helicobacter pylori infection stimulates intestinalization of endocrine cells in glandular stomach of Mongolian gerbils
- Significant Factors on Gastric Carcinogenesis Revealed by Experimental Animal Models
- Gastric and intestinal phenotypes and histogenesis of advanced glandular stomach cancers in carcinogen-treated, Helicobacter pylori-infected Mongolian gerbils
- Colonic and small-intestinal phenotypes in gastric cancers : Relationships with clinicopathological findings
- Susceptibility of Heterozygous and Nullizygous p53 Knockout Mice to Chemical Carcinogens : Tissue Dependence and Role of p53 Gene Mutations
- Coexistence of gastric-and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach
- Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils
- P6-38 Relationship between hepatic enzyme induction and carcinogenicity in the p53 deficient mice treated with aminophenylnorharman(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- β-Catenin gene alteration in glandular stomach adenocarcinomas in N-methyl-N-nitrosourea-treated and Helicobacter pylori-infected Mongolian gerbils
- Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa
- Detection of Initiating and Promoting Activity of Aminophenylnorharman with a Five-week In Vivo Initiation Assay
- β-Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas
- Tissue-dependent susceptibility of p53 knockout mice to chemical-induced carcinogenesis (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Effect of early eradication on Helicobacter pyloirirelated gastric carcinogenesis in Mongolian gerbils
- Gastric Carcinogenesis and Intestinalization Induced by N-methyl-N-nitrosourea in the Senescence-Accelerated Mouse (SAMP3)
- Earlier Helicobacter pylori Infection Increases the Risk for the N-Methyl-N-nitrosourea-induced Stomach Carcinogenesis in Mongolian Gerbils
- Tongue Carcinogenic Susceptibility of p53 Deficient Mice to Methyl-n-amylnitrosamine
- Synergistic Promoting Effects of Helicobacter pylori Infection and High-salt Diet on Gastric Carcinogenesis in Mongolian Gerbils
- Lack of a Dose-response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-Nitrosodiethylamine
- Appearance of Osteonectin-expressing Fibroblastic Cells in Early Rat Stomach Carcinogenesis and Stomach Tumors Induced with N-Methyl-N'-nitro-N-nitrosoguanidine
- The Effects of Allyl Alcohol-induced Cell Proliferation for Detection of Initiation Activities of Chemicals in Rat Liver
- Reversibility of Heterotopic Proliferative Glands in Glandular Stomach of Helicobacter pylori-infected Mongolian Gerbils on Eradication
- The Effects of D-galactosamine- or Carbon Tetrachloride-Induced Regeneration on Induction of Rat Liver Cell Foci in a Model for Detection of Initiation Activities of Chemicals
- Differential Effects of Partial Hepatectomy and Carbon Tetrachloride Administration on Induction of Liver Cell Foci in a Model for Detection of Initiation Activity
- More Frequent β-Catenin Gene Mutations in Adenomas than in Aberrant Crypt Foci or Adenocarcinomas in the Large Intestines of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated Rats
- Development and Distribution of 2-Amino- 1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced Aberrant Crypt Foci in the Rat Large Intestine
- Increased Expression of Sucrase and Intestinal-type Alkaline Phosphatase in Human Gastric Carcinomas with Progression.
- Expression of Sucrase and Intestinal-type Alkaline Phosphatase in Colorectal Carcinomas in Rats Treated with Methylazoxymethanol Acetate.
- Stable Expression of Glutathione S-transferase P-form mRNA and TGF-α Immunohistochemical Expression are Useful Markers for Identification of Persistent Nodules from an Early Stage in Rat Hepatocarcinogenesis
- N-Methyl-N-nitrosourea Concentration-dependent, Rather than Total Intake-dependent, Induction of Adenocarcinomas in the Glandular Stomach of BALB/c Mice
- Increased Expression of Sucrase and Intestinal-type Alkaline Phosphatase in Human Gastric Carcinomas with Progression
- Dose-dependent Promoting Effects of Catechol on Glandular Stomach Carcinogenesis in BALB/c Mice Initiated with N-Methyl-N-nitrosourea
- Sparse Distribution of Hepatocyte Growth Factor-producing Cells inside Hepatocellular Foci in Rats Treated with Hepatocarcinogens
- Gastric tumorigenicity of 1,2-dimethylhydrazine on the background of gastric intestinal metaplasia induced by X-irradiation in CD (SD) rats.
- Gastric Tumorigenicity of 1,2-Dimethylhydrazine on the Background of Gastric Intestinal Metaplasia Induced by X-Irradiation in CD (SD) Rats
- STEM CELLS AND GASTRIC CANCER : ROLE OF GASTRIC AND INTESTINAL MIXED INTESTINAL METAPLASIA
- Stem cells and gastric cancer : Role of gastric and intestinal mixed intestinal metaplasia
- Genetic analysis of steroid-induced osteonecrosis of the femoral head
- Progesterone Enhancement of Stomach Tumor Development in SD Rats Treated with N-Methyl-N'-nitro-N-nitrosoguanidine
- Influence of Previous Interferon Therapy on Recurrence after Resection of Hepatitis C Virus-related Hepatocellular Carcinoma
- Relationship between Multicentric Occurrence of Hepatocellular Carcinoma and Histology of Noncancerous Hepatic Tissue in Patients with Chronic Hepatitis C
- Effects of Continuous Hepatitis with Persistent Hepatitis C Viremia on Outcome after Resection of Hepatocellular Carcinoma
- Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
- Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head : a nationwide multicenter case-control study in Japan
- Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation
- Undifferentiated Sarcoma of the Salivary Gland in a Mongolian Gerbil (Meriones unguiculatus)
- Expression of Cathepsin E and Its Suppression with Intestinalization in Epithelial Cells and Tumor Cells in Rat Glandular Stomach Treated with N-methyl-N'-nitro-N-nitrosoguanidine